
Label detail
PT-141 + Oxytocin
20/10 mg
Nasal Spray · 10 mL
Bottle format
100 metered sprays
33 servings
Ready to use
Intimacy & Connection
PT-141 + Oxytocin
Sexual-arousal and bonding support.
Bremelanotide (PT-141), a melanocortin-receptor agonist studied in central pathways of sexual arousal, paired with oxytocin, the neuropeptide studied for its role in pair-bonding and social behavior.
Areas of study
Dosing is determined only by your prescriber and the pharmacy label. This page does not provide dosing instructions.
About this formulation
What is in PT-141 + Oxytocin
Bremelanotide (PT-141), a melanocortin-receptor agonist studied in central pathways of sexual arousal, paired with oxytocin, the neuropeptide studied for its role in pair-bonding and social behavior.
Intended program: Sexual-arousal and bonding support.
Peptide composition
PT-141 20 mg + Oxytocin 10 mg per 10 mL
Delivery route
Nasal Spray
Why this delivery format
The same formulation, without the injectable routine
Needle-free administration
No syringes and no injection-site routine.
Metered spray bottle
100 metered sprays per 10 mL bottle for consistent delivery.
No reconstitution
No powders to mix and no diluent to measure.
12-month room-temperature stability
Manufacturer-reported for sealed products within their labeled storage conditions.
Product details
- Peptide composition
- PT-141 20 mg + Oxytocin 10 mg per 10 mL
- Bottle strength
- 20/10 mg
- Delivery route
- Nasal Spray
- Bottle size
- 10 mL bottle
- Metered sprays
- 100 metered sprays
- Servings
- 33 servings
- Storage
- Store sealed at room temperature. Individual product labeling and pharmacy instructions always take precedence.
How the technology works
Licensed nano-encapsulation
The peptide is carried inside a nano-scale vehicle designed to protect it at the mucosal surface, hold against that surface, cross mucosal cell junctions, and support absorption — instead of relying on an injection.
The science behind the sprayImportant information
Prescription only. Dispensed by a licensed pharmacy for use in provider-supervised programs. Product information describes research areas and intended program categories, not established clinical outcomes. Not intended to diagnose, treat, cure, or prevent any disease.
Compounded formulations are not FDA-approved. Availability varies by state and is subject to applicable laws, prescription requirements, and pharmacy approval. Dosing and administration are determined solely by your prescriber and the dispensing pharmacy's label.
